Compare ADMA Biologics Inc (ADMA) vs Digital Realty Trust, Inc. (DLR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Digital Realty Trust, Inc. — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Digital Realty Trust, Inc. trades at $191.45 (market cap $70.61B). The key difference: Digital Realty Trust, Inc. is far larger — about 31.8× ADMA Biologics Inc's market cap, and Digital Realty Trust, Inc. pays a 2.56% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | DLR | |
|---|---|---|
Market Cap | $2.22B | $70.61B |
Sector | Health | Real Estate |
52-Week High | $20.38 | $203.91 |
52-Week Low | $7.60 | $147.93 |
Enterprise Value | $2.29B | $89.32B |
Dividend Yield | — | 2.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.78, up 0.31% today, with a bullish technical signal from moving averages and strong fundamentals including a 32.98% net income margin and 41.9% ROE. Recent earnings show a mix of beats and misses, with Q3 2026 EPS expected at $0.19. The stock faces headwinds from multiple class-action lawsuits alleging securities fraud, as reported by news outlets in August 2026.
Outlook is cautiously optimistic due to robust profitability and analyst support, but legal risks and recent earnings volatility pose challenges. Investment opportunity hinges on legal resolution and sustained earnings growth, with risks including litigation outcomes and competitive pressures in the biologics sector.
Digital Realty (DLR) trades at $196.84, up 2.9% with bullish technical signals and strong analyst support. The stock shows robust fundamentals with revenue growth from $5.6B in 2024 to $6.1B in 2025 and net income reaching $1.31B. Recent Q2 2026 earnings beat expectations with $1.21 EPS versus $0.48 expected, driven by record leasing activity and AI-driven data center demand. The company maintains a 63.8% buy rating from analysts with a $216.56 consensus target.
DLR presents a compelling growth opportunity leveraging AI infrastructure demand, though premium valuation metrics (P/E 241.53, P/S 25.08) warrant caution. Key risks include high debt levels ($15.1B long-term) and cyclical tech spending. Current price near the $197 low target suggests limited downside with 10% upside to consensus target, supported by strong cash flow generation and dividend payments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Digital Realty Trust, Inc.
Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →
